This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2021 Feb 11;384(6):489-491.

doi: 10.1056/NEJMp2033734. Epub 2021 Jan 13.

The Future of Drug-Pricing Transparency

William B Feldman¹, Benjamin N Rome¹, Jerry Avorn¹, Aaron S Kesselheim¹

Affiliations

Affiliation

¹ From the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics (W.B.F., B.N.R., J.A., A.S.K.) and the Division of Pulmonary and Critical Care Medicine (W.B.F.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School (W.B.F., B.N.R., J.A., A.S.K.) - both in Boston.

PMID: 33440087
DOI: 10.1056/NEJMp2033734

The Future of Drug-Pricing Transparency

William B Feldman et al. N Engl J Med. 2021.

. 2021 Feb 11;384(6):489-491.

doi: 10.1056/NEJMp2033734. Epub 2021 Jan 13.

Authors

William B Feldman¹, Benjamin N Rome¹, Jerry Avorn¹, Aaron S Kesselheim¹

Affiliation

¹ From the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics (W.B.F., B.N.R., J.A., A.S.K.) and the Division of Pulmonary and Critical Care Medicine (W.B.F.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School (W.B.F., B.N.R., J.A., A.S.K.) - both in Boston.

PMID: 33440087
DOI: 10.1056/NEJMp2033734

No abstract available

PubMed Disclaimer

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations